Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV-Reply

JAMA Intern Med. 2024 Jun 1;184(6):706-707. doi: 10.1001/jamainternmed.2024.0995.

Authors

Bruce Aldred^{1

2}, Robert H Lyles³, Valeria D Cantos^{1

2}

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
² The Ponce Center, Grady Health System, Atlanta, Georgia.
³ Rollins School of Public Health, Emory University, Atlanta, Georgia.

PMID: 38683580
DOI: 10.1001/jamainternmed.2024.0995

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
HIV Infections* / drug therapy
Humans
Mpox, Monkeypox

Substances

Antiviral Agents